Skip to primary navigation Skip to main content
0 item $0.00

Associate Professor Costan Magnussen

BHM(Hons) | PhD, University of Tasmania

Costan is an epidemiologist with his main research focus on the early life determinants of adult cardiovascular and metabolic (cardiometabolic) disease. This work has relied on data from long-term observational studies that began when participants were children and who have been followed-up over decades to mid adulthood, somewhat like the ”Up” TV series. His research vision is to provide the best evidence on important clinical and public health questions that will afford young people an optimal start in life — one that involves low relative and lifetime risk of clinical cardiometabolic outcomes.

Costan is a chief or principal investigator of the Childhood Determinants of Adult Health (CDAH) Study and the Cardiovascular Risk in Young Finns Study, and played a key role in the development of a major international collaboration that would become the International Childhood Cardiovascular Cohort (i3C) Consortium. He has a particular interest in harnessing observational epidemiological data to answer clinical and public health questions and fosters the development and use of new data analysis methods to answer new, or to better answer old, questions. He has held postdoctoral positions at the University of Turku, Finland, Murdoch Childrens Research Institute, and Menzies Institute for Medical Research. He is Adjunct Professor of cardiovascular epidemiology at the University of Turku, Finland, and is currently a National Health and Medical Research Council (NHMRC) Emerging Leader (EL2) Fellow.


  • NHMRC Emerging Leader (EL2) Fellowship (2020–2024)
  • Heart Foundation Future Leader Fellowship (2016–2020)
  • NHMRC Early Career Postdoctoral Research Fellow (2012–2016)


  • University of Tasmania Vice-Chancellor’s Award for Outstanding Research Performance by Early Career Researchers at Level A or B
  • Silver achievement award, University of Turku, Finland

Support us

With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.

Find out more